Heribert Jürgens

Heribert Jürgens

UNVERIFIED PROFILE

Are you Heribert Jürgens?   Register this Author

Register author
Heribert Jürgens

Heribert Jürgens

Publications by authors named "Heribert Jürgens"

Are you Heribert Jürgens?   Register this Author

44Publications

1189Reads

6Profile Views

Impact of the Interdisciplinary Tumor Board of the Cooperative Ewing Sarcoma Study Group on local therapy and overall survival of Ewing sarcoma patients after induction therapy.

Pediatr Blood Cancer 2018 12 7;65(12):e27384. Epub 2018 Aug 7.

Department of Pediatrics III, West German Cancer Centre, German Cancer Research Centre, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27384DOI Listing
December 2018

Impact of Whole Lung Irradiation on Survival Outcome in Patients With Lung Relapsed Ewing Sarcoma.

Int J Radiat Oncol Biol Phys 2018 11 3;102(3):584-592. Epub 2018 Jul 3.

Pediatrics III, Hematology/ Oncology, West German Cancer Center and German Cancer Research Center, University Hospital Essen, Essen, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.06.032DOI Listing
November 2018

Age dependency of primary tumor sites and metastases in patients with Ewing sarcoma.

Pediatr Blood Cancer 2018 09 1;65(9):e27251. Epub 2018 Jun 1.

University Hospital Essen, Pediatrics III, Sarcoma Centre, West German Cancer, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27251DOI Listing
September 2018

High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008.

J Clin Oncol 2018 Sep 6:JCO2018782516. Epub 2018 Sep 6.

Jeremy Whelan, University College Hospital; Ian Judson, Institute of Cancer Research, London; Bernadette Brennan, Royal Manchester Children's Hospital, Manchester; Bruce Morland, Birmingham Children's Hospital; Keith Wheatley, University of Birmingham, Birmingham; Ian Lewis, Leeds Community Healthcare National Health Service Trust, Leeds; Alan Craft, Newcastle University, Newcastle upon Tyne, United Kingdom; Marie-Cecile Le Deley and Cyril Lervat, Centre Oscar Lambret, Lille; Gwénaël Le Teuff, Nathalie Gaspar, and Odile Oberlin, Institut Gustave Roussy, Villejuif; Jean-Yves Blay, Centre Léon Bérard; Perrine Marec-Berard, Institute of Pediatric Onco-Haematology, Lyon; Marie-Pierre Castex, Centre Hospitalier Universitaire de Toulouse, Toulouse; Jean-Claude Gentet, Centre Hospitalier Universitaire La Timone, Marseille; Marta Jimenez, Unicancer; Valerie Laurence and Jean Michon, Institut Curie, Paris; France; Uta Dirksen, Sebastian Bauer, Andreas Ranft, University Hospital Essen, Essen; Susanne Amler, Institut für Biometrie und Klinische Forschung; Wolfgang Hartmann and Heribert Juergens, Universitätsklinikum, Münster, Münster; Stefan Bielack, Klinikum Stuttgart, Stuttgart; Stefan Burdach, Comprehensive Cancer Center, München; Dagmar Dilloo, University-Clinic Bonn, Bonn; Angelika Eggert, Charité University; Peter Reichardt, HELIOS Klinikum Berlin-Buch, Berlin; Wolf-Achim Hassenpflug, University Medical Center Hamburg-Eppendorf, Hamburg; Thomas Klingebiel, Childrens University Hospital, Frankfurt; Udo Kontny, University Medical Center Aachen, Aachen; Michael Paulussen, Children's and Adolescents' Hospital, Datteln; Germany; Douglas S. Hawkins, Seattle Children's Hospital, Seattle, WA; Hans Gelderblom, Leiden University Medical Center, Leiden; Hendrik van den Berg, University of Amsterdam, Amsterdam, the Netherlands; Lars Hjorth, Skane University Hospital, Lund, Sweden; Jarmila Kruseova, Faculty Hospital Motol Prague, Prague, Czech Republic; Ruth Ladenstein, St Anna Children's Hospital and Children's Cancer Research Institute, Vienna, Austria; Sandrine Marreaud, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.2516
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.2516DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209090PMC
September 2018

Results for patients with sarcoma not otherwise specified and other diagnoses than Ewing sarcoma treated according to the Euro-EWING 99 trial.

Pediatr Blood Cancer 2017 Oct 24;64(10). Epub 2017 Apr 24.

Department of Pediatric Hematology and Oncology, University Hospital Muenster, Westfalian Wilhelms University, Muenster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26524DOI Listing
October 2017

Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group.

Eur J Cancer 2016 07 10;61:128-36. Epub 2016 May 10.

Biostatistics Unit, Gustave Roussy, Villejuif, France; CESP Centre for Research in Epidemiology and Population Health, INSERM U1018, Team-2, Paris-Sud University, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.03.075DOI Listing
July 2016

Management and Outcome of Ewing Sarcoma of the Head and Neck.

Pediatr Blood Cancer 2016 Apr 24;63(4):604-10. Epub 2015 Dec 24.

Department of Pediatric Hematology and Oncology, University Hospital Muenster, Muenster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25830DOI Listing
April 2016

Ewing Sarcoma: Current Management and Future Approaches Through Collaboration.

J Clin Oncol 2015 Sep 24;33(27):3036-46. Epub 2015 Aug 24.

Nathalie Gaspar, Marie-Cecile Le Deley, and Odile Oberlin, Institut Gustave Roussy, Villejuif; Nathalie Gaspar, Marie-Cecile Le Deley, Line Claude, Olivier Delattre, Jean Michon, Perrine Marec-Bérard, and Odile Oberlin, Société Française de Lutte Contre les Cancers et les Leucémies de l'Enfant et de l'Adolescent; Marie-Cecile Le Deley, Paris-Sud University, Le Kremlin-Bicêtre; Line Claude and Perrine Marec-Bérard, Centre Léon-Bérard, Lyon; Olivier Delattre and Jean Michon, Institut Curie, Paris, France; Douglas S. Hawkins, Seattle Children's Hospital, Seattle, WA; Douglas S. Hawkins, Mark L. Bernstein, and Richard B. Womer, Children's Oncology Group; Uta Dirksen and Heribert Juergens, University Hospital Münster, Münster; Uta Dirksen, Michael Paulussen, and Heribert Juergens, Gesellschaft für Pädiatrische Onkologie und Hämatologie; Michael Paulussen, Children's and Adolescents' Hospital, Witten/Herdecke University, Datteln, Germany; Ian J. Lewis, Alder Hey Children's National Health Service (NHS) Foundation Trust, Liverpool; Ian J. Lewis, Robert Grimer, Bernadette Brennan, and Alan W. Craft, Children's Cancer and Leukaemia Group; Robert Grimer, Royal Orthopaedic Hospital, Birmingham; Jeremy Whelan, University College London Hospital NHS Foundation Trust; Ian Judson, Royal Marsden Hospital, London; Bernadette Brennan, Royal Manchester Children's Hospital, Manchester; Alan W. Craft, Royal Victoria Infirmary, Newcastle, United Kingdom; Stefano Ferrari and Piero Picci, Rizzoli Institute, Bologna; Stefano Ferrari, Piero Picci, Roberto Luksch, Italian Sarcoma Group; Roberto Luksch, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy; Heinrich Kovar and Ruth Ladenstein, Children's Cancer Institute, St Anna Kinderkrebsforschung, Wien; Heinrich Kovar and Ruth Ladenstein, Arbeitsgemeinschaft Ambulant Tätiger Pädiatrischer Onkologen und Hämatologen, Vienna, Austria; Jeremy Whelan and Ian Judson, European O

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/27/3036.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.59.5256
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.5256DOI Listing
September 2015

More on osteosarcoma and phylloides tumor.

J Pediatr Hematol Oncol 2015 Mar;37(2):158-9

*Klinikum Stuttgart, Olgahospital Pediatrics 5 (Oncology, Hematology Immunology), Stuttgart †Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000000197DOI Listing
March 2015

Diffuse hemorrhagic colitis in a patient with dyskeratosis congenita after nonmyeloablative allogeneic hematopoietic stem cell transplantation.

J Pediatr Hematol Oncol 2015 Jan;37(1):e41-4

*Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster †Department of Medicine B, University Hospital Muenster, Muenster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000000208DOI Listing
January 2015

Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.

Pediatr Blood Cancer 2015 Jan 22;62(1):40-4. Epub 2014 Sep 22.

Department of Clinical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25230DOI Listing
January 2015

Complex MLL rearrangement in non-infiltrated bone marrow in an infant with stage II precursor B-lymphoblastic lymphoma.

Eur J Haematol 2014 Oct 28;93(4):349-53. Epub 2014 Apr 28.

Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12314DOI Listing
October 2014

Common Ewing sarcoma-associated antigens fail to induce natural T cell responses in both patients and healthy individuals.

Cancer Immunol Immunother 2014 Oct 28;63(10):1047-60. Epub 2014 Jun 28.

Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Albert-Schweitzer Campus 1, 48149, Münster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-014-1574-3DOI Listing
October 2014

Anchorage-independent growth of Ewing sarcoma cells under serum-free conditions is not associated with stem-cell like phenotype and function.

Oncol Rep 2014 Aug 13;32(2):845-52. Epub 2014 Jun 13.

Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, D-48149 Muenster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2014.3269DOI Listing
August 2014

Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.

J Clin Oncol 2014 Aug 30;32(23):2440-8. Epub 2014 Jun 30.

Odile Oberlin, Gustave Roussy Institute, Villejuif; Marie-Cécile Le Deley, Université Paris-Sud, Le Kremlin-Bicêtre; Jean Michon, Institut Curie, Paris; Perrine Marec-Bérard, Centre Léon-Bérard, Lyon, France; Michael Paulussen, Vestische Kinder-und Jugendklinik Datteln, Witten/Herdecke University, Datteln; Andreas Ranft, Heribert Juergens, and Uta Dirksen, University Hospital Münster, Münster, Germany; Ian Lewis, Alder Hey Children's National Health Service Foundation Trust, Liverpool; Bernadette Brennan, Royal Manchester Children's Hospital, Manchester; Jeremy Whelan, University College London Hospital National Health Service Foundation Trust; Ian Judson, The Royal Marsden Hospital, London; Keith Wheatley, University of Birmingham, Birmingham; Alan Craft, Royal Victoria Infirmary, Newcastle, United Kingdom; Ruth Ladenstein, St Anna Children's Cancer Research Institute, Vienna, Austria; Henk van den Berg, Emma Children Hospital AMC, Amsterdam, the Netherlands; and Lars Hjorth, Skåne University Hospital, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.4833DOI Listing
August 2014

Osteosarcoma treatment - where do we stand? A state of the art review.

Cancer Treat Rev 2014 May 27;40(4):523-32. Epub 2013 Nov 27.

Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2013.11.006DOI Listing
May 2014

Late graft failure in FA--case report and review of the literature.

Pediatr Transplant 2012 Dec 23;16(8):E360-3. Epub 2012 May 23.

Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1399-3046.2012.01719.xDOI Listing
December 2012

Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens.

Cancer Immunol Immunother 2012 Mar 18;61(3):385-96. Epub 2011 Sep 18.

Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-011-1111-6DOI Listing
March 2012

New targets and targeted drugs for the treatment of cancer: an outlook to pediatric oncology.

Pediatr Hematol Oncol 2011 Oct;28(7):539-55

Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/08880018.2011.613094DOI Listing
October 2011

The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES).

Cancer 2010 Jan;116(2):443-50

University Children's Hospital Muenster, Department of Pediatric Hematology and Oncology, 48149 Muenster, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.24740
Publisher Site
http://dx.doi.org/10.1002/cncr.24740DOI Listing
January 2010

2B4 (CD244) signaling via chimeric receptors costimulates tumor-antigen specific proliferation and in vitro expansion of human T cells.

Cancer Immunol Immunother 2009 Dec 10;58(12):1991-2001. Epub 2009 Apr 10.

Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Münster, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-009-0704-9
Publisher Site
http://dx.doi.org/10.1007/s00262-009-0704-9DOI Listing
December 2009

Aetiology of childhood acute leukaemias: current status of knowledge.

Radiat Prot Dosimetry 2008 15;132(2):114-8. Epub 2008 Oct 15.

Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Albert-Schweitzer-Str. 33, D-48149 Muenster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rpd/ncn269DOI Listing
May 2009

Gene-engineered varicella-zoster virus reactive CD4+ cytotoxic T cells exert tumor-specific effector function.

Cancer Res 2007 Sep;67(17):8335-43

Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-4426DOI Listing
September 2007